APHRIA INC (NASDAQOTH:APHQF)

CAPS Rating: 1 out of 5

APHQF News and Commentary

Caps

How do you think APHQF will perform against the market?

Add Stock to CAPS Watchlist

All Players

13 Outperform
27 Underperform
 

All-Star Players

4 Outperform
24 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top APHQF Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

stocksracer (52.18)
Submitted June 03, 2017

Pure Pot Play - Canadian Company - If Legal Pot is approved in Canada, this company could benefit significantly. Fool has a very good article on this company.

SmartAce (99.94)
Submitted April 12, 2017

I just spent the day painting our fence. All I know is tomorrow I better be able to do karate.

APHQF VS S&P 500 (SPY)

APHQF Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about APHQF.

Recs

0
Member Avatar SmartAce (99.94) Submitted: 10/17/2017 1:05:23 PM : Underperform Start Price: $5.63 APHQF Score: +3.24

Texting my wife when we were dating - What are you wearing?
Texting my wife now - Did the dog poop?

Recs

0
Member Avatar InvestorDeb (69.24) Submitted: 10/13/2017 3:44:03 PM : Outperform Start Price: $6.23 APHQF Score: -12.74

Canada is creeping closer to the July 1 deadline where it will legalize medical marijuana. The Canadian government appears to be fairly regulating marijuana, and as it begins to gain mass production, it could mean major wins for producers around the country.

A decade from now, there will likely be a few major players in the cannabis space. Aphasia just reported strong earnings today, here are some of the operating highlights:

Eighth consecutive quarter of positive EBITDA. $1.5 million in EBITDA from operations in the quarter, a 47% increase from the prior year.
First harvest and first sale of product flowered exclusively in the new facility expansion.
Construction on Part III and Part IV expansion progressing as scheduled with first sale from Part III expected in late May 2018 and from Part IV in mid-to-late January 2019. Economies of scale achieved as a result of the completion of these expansion projects will further promote Aphria's commitment to being one of the lowest cost producers in the industry.
Improved "all-in" costs to produce dried cannabis per gram from $1.67 to $1.61 in the quarter, a decrease of 3.5%.
Lowered cash costs to produce dried cannabis per gram from $1.11 to $0.95 in the quarter, a decrease of 14.4%.
Made the step change in the quarter from a company reporting cumulative losses greater than cumulative net income (deficit) to cumulative net income exceeding cumulative losses (retained earnings). Aphria becomes one of only a few publicly listed Licensed Producers in this position.
Deployed approximately $20.1 million of capital in the form of strategic investments including additional investments in Copperstate Farms Investors, LLC, Green Acre Capital Fund I and investments in TS BrandCo Holdings Inc., HydRX Farms Inc. (d/b/a Scientus Pharma) and Nuuvera Corp.
Deployed approximately $23.7 million of capital in the form of capital expenditures related to our Part II, Part III and Part IV expansion projects.
"In the first quarter of 2018, Aphria increased revenue and grams sold, and lowered cash costs, in addition to recording our eighth consecutive quarter of positive EBITDA," said Vic Neufeld, Chief Executive Officer, Aphria. "A key driver of our continued performance has been our ability to maintain leadership as one of the lowest-cost producers in the industry. As legal recreational cannabis comes into market in 2018, low costs per gram will be a critical factor for the entire supply chain. Our proven ability to grow to scale while keeping costs low is an important competitive advantage; it positions Aphria to profitably meet projected demand for cannabis and deliver sustainable value to our shareholders."
"Looking ahead, we are on track to meet critical short- and long-term goals: Our fully-funded facility expansion is well underway, and we expect to achieve further economies of scale once the expansion projects are completed in 2018. Additionally, we continue to develop new product innovations and invest in our recreational infrastructure and brand. This will enable us to serve growing demand from medical cannabis patients in the near term and will eventually support Aphria's position as a leader in Canada's recreational market, once federal and provincial regulatory frameworks are in place," said Mr. Neufeld.

These companies carry incredible risk. Limiting the size of such a speculative position to 5% of my portfolio is the rule of thumb I use. First tranche purchased today...

Recs

0
Member Avatar KingMR012 (< 20) Submitted: 8/3/2017 6:14:03 PM : Outperform Start Price: $4.47 APHQF Score: +18.92

They are the lowest cost producer of all cannabis companies approved by Health Canada. They are focusing on medical over recreational. By mid 2018 they will have over 1M SF of grow area.

Leaderboard

Find the members with the highest scoring picks in APHQF.

Score Leader

stocksracer

stocksracer (52.18) Score: +41.33

The Score Leader is the player with the highest score across all their picks in APHQF.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
stocksracer 52.18 6/6/2017 Outperform 5Y $3.74 +46.99% +5.66% +41.33 1 Comment
sirhc1978 74.79 6/9/2017 Outperform 5Y $3.76 +46.01% +5.33% +40.68 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. upatthewire88 91.48 6/28/2017 Outperform 5Y $4.09 +34.39% +6.02% +28.37 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. KingMR012 < 20 8/4/2017 Outperform 5Y $4.47 +22.79% +3.87% +18.92 1 Comment
JoeySolitro1 99.99 4/12/2017 Underperform 5Y $5.99 -8.38% +9.89% +18.27 0 Comment
TSIF 99.97 4/12/2017 Underperform 1Y $5.73 -4.19% +9.58% +13.76 0 Comment
bckearns 79.35 4/12/2017 Underperform 5Y $5.70 -3.68% +9.74% +13.42 0 Comment
ershler 91.56 5/12/2017 Outperform 5Y $4.54 +20.93% +7.54% +13.39 0 Comment
Gmoney70 82.13 5/8/2017 Outperform 5Y $4.56 +20.53% +7.24% +13.29 0 Comment
kdakota630 29.70 10/5/2017 Underperform 3M $6.16 -10.88% +0.98% +11.86 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for APHQF.

Featured Broker Partners